GlassScriptPhysician profile
Brian A Berelowitz
NPI 1356308357
$4,986.41
in general payments reported to CMS, 2019-2025
37 companies · $683 in 2025
The $683 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,345 · 2020: $443 · 2021: $299 · 2022: $1,340 · 2023: $477 · 2024: $400 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491 · Education: $69.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.55 |
| Education | $69.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,110.18 | 2019-2022 | |
| Novo Nordisk INC | $389.41 | 2019-2025 | Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $334.95 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $316.30 | 2022-2024 | |
| Ascendis Pharma Endocrinology INC | $248.39 | 2025 | Yorvipath |
| Astrazeneca Pharmaceuticals LP | $239.01 | 2019-2022 | |
| Mannkind Corporation | $231.66 | 2019-2025 | Afrezza |
| Merck Sharp & Dohme LLC | $201.89 | 2019-2021 | |
| Renalytix Ai, INC. | $188.02 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Sanofi-Aventis U.S. LLC | $176.00 | 2019-2021 | |
| Corcept Therapeutics | $141.85 | 2019-2021 | |
| Medtronic Minimed, INC. | $141.32 | 2019 | |
| Neurocrine Biosciences, INC. | $138.35 | 2025 | |
| Beta Bionics, INC. | $133.90 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Chiesi USA, INC. | $124.97 | 2024 | Mycapssa |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $97.34 | 2019 | |
| Xeris Pharmaceuticals, INC. | $84.51 | 2021-2024 | Gvoke Hypopen, Recorlev |
| Lilly USA, LLC | $83.73 | 2021-2024 | Mounjaro |
| Insulet Corporation | $79.05 | 2019-2022 | |
| Radius Health, INC. | $65.94 | 2021-2024 | Tymlos |
| Boston Scientific Corporation | $58.35 | 2020-2023 | |
| Abbvie INC. | $48.77 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $48.17 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $32.86 | 2019-2022 | |
| Abbott Laboratories | $32.18 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.82 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $29.27 | 2019 | |
| Recordati_rare_diseases_inc. | $28.38 | 2023 | Isturisa, Signifor Lar |
| Amryt Pharma Holdings LTD | $25.59 | 2021-2022 | |
| Ibsa Pharma INC. | $20.13 | 2023 | Tirosint, Licart |
| Alexion Pharmaceuticals, INC. | $20.11 | 2019 | |
| Lifescan, INC. | $18.87 | 2019 | |
| Esperion Therapeutics, INC. | $16.03 | 2021 | |
| Medtronic, INC. | $14.94 | 2021 | |
| Antares Pharma, INC. | $11.81 | 2022 | |
| Dexcom, INC. | $11.41 | 2021 | |
| Companion Medical, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Berelowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.